Related content

Neuroprotection by the Kappa-Opioid Receptor Agonist, BRL52537, is Mediated via Up-Regulating Phosphorylated Signal Transducer and Activator of Transcription-3 in Cerebral Ischemia/Reperfusion Injury in Rats

By Fang Shudong   Xu Hui   Lu Junrui   Zhu Yesen   Jiang Hong  

Neurochemical Research, Vol. 38, Iss. 11, 2013-11 ,pp. : 2305-2312

Springer Publishing Company

Access to resources Recommend Favorite

Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa

By Marin C.   Bove J.   Bonastre M.   Tolosa E.  

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 66-73

Elsevier

Access to resources Recommend Favorite

Craniofacial reconstruction as a treatment for elevated intracranial pressure

By Baird Lissa   Gonda David   Cohen Steven   Evers Lars   LeFloch Nathalie   Levy Michael   Meltzer Hal  

Child's Nervous System, Vol. 28, Iss. 3, 2012-03 ,pp. : 411-418

Springer Publishing Company

Access to resources Recommend Favorite

Kappa‐opioid receptors differentially regulate low and high levels of ethanol intake in female mice

By  

Brain And Behavior, Vol. 6, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential time course of effects of κ-opioid agonist treatment on dynorphin a levels and κ-opioid receptor density

By D’Addario Claudio   Benedetto Manuela   Izenwasser Sari   Candeletti Sanzio   Romualdi Patrizia  

Journal of Molecular Neuroscience, Vol. 24, Iss. 2, 2004-06 ,pp. : 307-314

Humana Press, Inc

Access to resources Recommend Favorite